$ARDX

$3.06▲ +1.0% YTD

6 SEC 13D/G filings tracked · Last updated Nov 3, 2026

Filing History

CP $3.06▲ +1.0%Nov 3, 2026 · ThinkSabio Blog

$ARDX - Ardelyx Completes Enrollment in Phase 3 ACCEL Clinical Trial of IBSRELA® (tenapanor) in Adults with Chronic Idiopathic Constipation…

News

ARDX ▼ -3.8% - Ardelyx, Inc.

CP $3.08▲ -3.8%Oct 23, 2026 · ThinkSabio Blog

$ARDX - Ardelyx Presents Real-World Data at ASN Kidney Week 2026 Showing Serum Phosphate Reductions Following XPHOZAH® (tenapanor) Initiation With or…

News

ARDX ▲ +0.9% - Ardelyx, Inc.

CP $3.30▲ +0.9%Oct 12, 2026 · ThinkSabio Blog

$ARDX - Ardelyx Presents Real-World Data at ACG 2026 Showing Reduced Healthcare Resource Utilization Following IBSRELA® Initiation in Adults with IBS-…

News

ARDX ▲ +0.6% - Ardelyx, Inc.

CP $3.41▲ +0.6%Sep 30, 2026 · ThinkSabio Blog

$ARDX - Ardelyx Earns Multiple Honors at the 2026 PM360 Trailblazer Awards…

News

ARDX ▼ -0.3% - Ardelyx, Inc.

CP $3.77▲ -0.3%Sep 1, 2026 · ThinkSabio Blog

$ARDX - Ardelyx to Participate in Upcoming Investor Conferences…

SEC 13D/G

ARDX - Ardelyx, Inc. - SEC Filing Update (11-AUG-2026) | ThinkSabio - Stocks Simplified

$3.94▼ -35.93%Aug 11, 2026 · ThinkSabio Blog

$ARDX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #ARDX Ardelyx, Inc. : $3.94 Sector: Healthcare | YTD: 🔽 -35.93%…